Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
News Release - 20 April 2015
Global Fund Launches Online Platform for Strategy Development
News Release - 01 April 2015
Global Fund Affirms Commitment to Resilient Health Systems
Global Fund Board Selects New Chair and Vice-Chair
News Release - 25 March 2015
Reuters Corrects Inaccurate Article on Global Fund Grants to Malawi
Announcement - 25 March 2015
Doing the Right Thing: Human Rights for Those Affected by TB
This document presents the financial statements of the Global Fund for the financial year 2014.
20 April 2015
Nets and Knowledge to Protect Every Household in Papua New Guinea
09 April 2015
Protecting Millions of People Against Malaria in Chad
02 April 2015
HIV ‘Info-tainment’ at an Open-Air Cinema in Tanzania
One-third of humanity carries the tuberculosis bacilli. In most cases, it will remain latent and people will never develop the disease. Tuberculosis is transmitted by air, through coughing and sneezing. One person with untreated active TB can transmit the disease to up to 15 other people in a year. Without proper support and treatment, up to two-thirds of people who develop TB will die.
Although TB can affect anyone, the disease is closely linked to poverty. Those living in crowded, unsanitary living conditions, who suffer from poor nutrition, or who use tobacco all live at higher risk of developing TB. Those whose immune systems are compromised are at particular risk, which is why TB is the number one cause of death among people living with HIV. Migrants, miners, prisoners, children in contact with TB cases and people who use drugs are among the most vulnerable groups.
The important thing to remember is that TB is both preventable and treatable.
Over the past dozen years, a concerted global effort has managed to halt the spread of TB. Treatment has saved the lives of more than 37 million people between 2000 and 2013. Unfortunately, however, there remains a huge gap in services. Of the nearly 9 million people who developed TB in 2012, 3 million of them were not diagnosed and thus not treated or not notified to their national program. Many people are not being reached with information and services.
There are a number of challenges in fighting TB. Diagnosis can be difficult, particularly in cases of multidrug-resistant forms of the disease. Fortunately, new tools have been introduced in recent years which greatly reduce the amount of time required for a diagnosis.
Treatment is also difficult. Standard TB involves six months of daily medication, which can be very hard on patients, particularly those who live in poverty and cannot afford the time away from earning a living, whereas multidrug-resistant TB (MDR-TB) requires up to two years of treatment at a cost up to 200 times more expensive than standard treatment.
Stigma and discrimination can also be a barrier, leaving people too fearful to seek out treatment. Which is why education is a critical component of any plan to fight TB.
The Global Fund has helped to accelerate case detection and successful treatment in recent years, along with patient support and education initiatives. At the end of 2014, 12.3 million cases of smear-positive TB and 150,000 cases of multidrug-resistant TB had been detected and treated by Global Fund-supported programs. Global Fund financing supports countries to introduce and scale up new diagnostic tools and new drugs for TB. The Global Fund provides more than three-quarters of all international financing for TB.
New smear-positive TB cases detected and treated
21 March 2014 - Special Feature
Reach the 3 million: Find, Treat, Cure TB - World TB Day 2014
A guide to monitoring and evaluation for collaborative TB/HIV activities
Multidrug-resistant tuberculosis (MDR-TB)
Global Plan to Stop TB 2011-2015 TB/HIV
Pursue high-quality DOTS expansion and enhancement
WHO: Tuberculosis Global Facts
The Global Fund is committed to the highest standards of accountability and responsibility. If you have heard of any instance of inappropriate use of money related to the Global Fund, please report it immediately, here: Report Fraud and Abuse
© 2015 The Global Fund to Fight AIDS, Tuberculosis and Malaria